Update on the Management of High-Risk Squamous Cell Carcinoma

Seminars in Cutaneous Medicine and Surgery

Volumn 30, Issue 1, 2011, Pages 26-34

  LeBoeuf, Nicole R ^a   Schmults, Chrysalyne D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CAPECITABINE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; INTERFERON; METHOTREXATE;

CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOSURGERY; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; MONOTHERAPY; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOCOMPROMISED HOST; RADIOTHERAPY, ADJUVANT; SKIN NEOPLASMS;

EID: 79955426030     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2011.02.002     Document Type: Review

References (99)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin 1999, 49:8-31.
2. Scotto J., Kopf A.W., Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 1974, 34:1333-1338.
3. Fears T.R., Scotto J. Estimating increases in skin cancer morbidity due to increases in ultraviolet radiation exposure. Cancer Invest 1983, 1:119-126.
4. Chuang T.Y., Reizner G.T., Elpern D.J., et al. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kaua'i, Hawaii: An incidence report. J Am Acad Dermatol 1995, 33:422-426.
5. Harris R.B., Griffith K., Moon T.E. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001, 45:528-536.
6. Athas W.F., Hunt W.C., Key C.R. Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 2003, 12:1105-1108.
7. Miller DL, Weinstock MA: Non-melanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 30:774-778.
8. Karagas M.R., Greenberg E.R., Spencer S.K., et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999, 17:555-559.
9. Johnson T.M., Rowe D.E., Nelson B.R., et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992, 26:467-484.
10. Brantsch K.D., Meisner C., Schonfisch B., et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: A prospective study. Lancet Oncol 2008, 9:713-720.
11. Mourouzis C., Boynton A., Grant J., et al. Cutaneous head and neck SCCs and risk of nodal metastasis-UK experience. J Craniomaxillofac Surg 2009, 37:443-447.
12. Alam M., Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001, 344:975-983.
13. Kwa R.E., Campana K., Moy R.L. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992, 26:1-26.
14. English D.R., Armstrong B.K., Kricker A., et al. Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: A case-control study. Int J Cancer 1998, 76:628-634.
15. Preston D.S., Stern R.S. Nonmelanoma cancers of the skin. N Engl J Med 1992, 327:1649-1662.
16. Leiter U., Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer-The role of sunlight. Adv Exp Med Biol 2008, 624:89-103.
17. Masini C., Fuchs P.G., Gabrielli F., et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003, 139:890-894.
18. Wong S.S., Tan K.C., Goh C.L. Cutaneous manifestations of chronic arsenicism: Review of seventeen cases. J Am Acad Dermatol 1998, 38:179-185.
19. Herman S., Rogers H.D., Ratner D. Immunosuppression and squamous cell carcinoma: A focus on solid organ transplant recipients. Skinmed 2007, 6:234-238.
20. Mehrany K., Weenig R.H., Lee K.K., et al. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol 2005, 53:1067-1071.
21. Nguyen P., Vin-Christian K., Ming M.E., et al. Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol 2002, 138:758-763.
22. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol 2002, 27:616-623.
23. Clark R.A., Huang S.J., Murphy G.F., et al. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med 2008, 205:2221-2234.
24. Miller S., Alam M., Andersen J., et al. Basal cell and squamous cell skin cancers. J Natl Compr Cancer Netw 2010, 8:836-864.
25. Sober A. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. AJCC Cancer Staging Manual 2010, Springer, New York. (ed 7). S.B. Edge (Ed.).
26. Jambusaria-Pahlajani A., Hess S.D., Katz K.A., et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol 2010, 146:1225-1231.
27. Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26:976-990.
28. Cherpelis B.S., Marcusen C., Lang P.G. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002, 28:268-273.
29. Mullen J.T., Feng L., Xing Y., et al. Invasive squamous cell carcinoma of the skin: Defining a high-risk group. Ann Surg Oncol 2006, 13:902-909.
30. Moller R., Reymann F., Hou-Jensen K. Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol 1979, 115:703-705.
31. Edwards M.J., Hirsch R.M., Broadwater J.R., et al. Squamous cell carcinoma arising in previously burned or irradiated skin. Arch Surg 1989, 124:115-117.
32. Ayyappan K., Ananthatkrishnan N., Sankaran V. Can regional lymph node involvement be predicted in patients with carcinoma of the penis?. Br J Urol 1994, 73:549-553.
33. Magrina J.F., Gonzalez-Bosquet J., Weaver A.L., et al. Primary squamous cell cancer of the vulva: Radical versus modified radical vulvar surgery. Gynecol Oncol 1998, 71:116-121.
34. Gerard J.P., Chapet O., Samiei F., et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: Experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001, 92:77-84.
35. Stehman F.B., Bundy B.N., Ball H., et al. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: A Gynecologic Oncologic Group study. Am J Obstet Gynecol 1996, 174:1128-1133.
36. Dinehart S.M., Pollack S.V. Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989, 21:241-248.
37. Kraus D.H., Carew J.F., Harrison L.B. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998, 124:582-587.
38. Tavin E., Persky M. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope 1996, 106:156-158.
39. Clayman G.L., Lee J.J., Holsinger F.C., et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005, 23:759-765.
40. Goepfert H., Dichtel W.J., Medina J.E., et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984, 148:542-547.
41. Ross A.S., Whalen F.M., Elenitsas R., et al. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: An investigator-blinded retrospective cohort study. Dermatol Surg 2009, 35:1859-1866.
42. Breuninger H., Schaumburg-Lever G., Holzschuh J., et al. Desmoplastic squamous cell carcinoma of skin and vermilion surface: A highly malignant subtype of skin cancer. Cancer 1997, 79:915-919.
43. Jensen P., Hansen S., Moller B., et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999, 40:177-186.
44. Adamson R., Obispo E., Dychter S., et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: A single-center study. Transplant Proc 1998, 30:1124-1126.
45. Ong C.S., Keogh A.M., Kossard S., et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999, 40:27-34.
46. Meyer T., Arndt R., Nindl I., et al. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int 2003, 16:146-153.
47. Bouwes-Bavinck J.N., Hardie D.R., Green A., et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996, 61:715-721.
48. Euvard S., Kanitakis J., Decullier E., et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006, 81:1093-1100.
49. Smith K.J., Hamza S., Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004, 30:634-641.
50. Carucci J.A., Martinez J.C., Zeitouni N.C., et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: Clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004, 30:651-655.
51. Veness M.J., Quinn D.I., Ong C.S., et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience. Cancer 1999, 85:1758-1764.
52. Otley C.C., Maragh S.L. Reduction of immunosuppression for transplant-associated skin cancer: Rationale and evidence of efficacy. Dermatol Surg 2005, 31:163-168.
53. Frierson H.F., Deutsch B.D., Levine P.A. Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 1988, 19:1397-1402.
54. Kinlen L.J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985, 78:44-49.
55. Fine J.D., Johnson L.B., Weiner M., et al. Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009, 60:203-211.
56. Yousem D.M., Som P.M., Hackney D.B., et al. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992, 182:753-759.
57. Ginsberg L.E. MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am 2002, 10:511-525.
58. Williams L.S., Mancuso A.A., Mendenhall W.M. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001, 49:1061-1069.
59. Land R., Herod J., Moskovic E., et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2006, 16:312-317.
60. Cho S.B., Chung W.G., Yun M., et al. Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: Retrospective analysis of 12 patients. Dermatol Surg 2005, 31:442-446. discussion: 6-7.
61. Bailet J.W., Abemayor E., Jabour B.A., et al. Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992, 102:281-288.
62. Ross A.S., Schmults C.D. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: A systematic review of the English literature. Dermatol Surg 2006, 32:1309-1321.
63. Veness M.J., Morgan G.J., Palme C.E., et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: Combined treatment should be considered best practice. Laryngoscope 2005, 115:870-875.
64. Chuang T.Y., Popescu N.A., Su P.D., et al. Squamous cell carcinoma. A population-based incidence study in Rochester, Minn. Arch Dermatol 1990, 126:185-188.
65. Talmi Y.P., Horowitz Z., Wolf M., et al. Delayed metastases in skin cancer of the head and neck: the case of the "known primary". Ann Plast Surg 1999, 42:289-292.
66. Brodland D.G., Zitelli J.A. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992, 27:241-248.
67. Lawrence N., Cottel W.I. Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol 1994, 31:30-33.
68. Leibovitch I., Huilgol S.C., Selva D., et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005, 53:253-260.
69. Veness M., Richards S. Role of modern radiotherapy in treating skin cancer. Australas J Dermatol 2003, 44:159-166. quiz: 67-68.
70. Kwan W., Wilson D., Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 2004, 60:406-411.
71. Veness M.J., Ong C., Cakir B., et al. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980-1997. Australas Radiol 2001, 45:195-199.
72. Radiation Oncology: Rationale, Techniques, Results 2003, Mosby, Philadelphia, PA. (ed 8). J. Cox (Ed.).
73. Cartei G., Cartei F., Interlandi G., et al. Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged. Am J Clin Oncol 2000, 23:181-184.
74. Wollina U., Hansel G., Koch A., et al. Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin. J Cancer Res Clin Oncol 2005, 131:300-304.
75. Hitt R., Jimeno A., Rodriguez-Pinilla M., et al. Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors. Br J Cancer 2004, 91:2005-2011.
76. Bentzen J.D., Hansen H.S. Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region. Head Neck 2007, 29:47-51.
77. Kim J.G., Sohn S.K., Kim D.H., et al. Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. Br J Cancer 2005, 93:1117-1121.
78. Shimizu T., Izumi H., Oga A., et al. Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology 2001, 202:203-206.
79. Suen J.K., Bressler L., Shord S.S., et al. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab. Anti Cancer Drugs 2007, 18:827-829.
80. Bauman J.E., Eaton K.D., Martins R.G. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab. Arch Dermatol 2007, 143:889-892.
81. Arnold A.W., Bruckner-Tuderman L., Zuger C., et al. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology 2009, 219:80-83.
82. Jalili A., Pinc A., Pieczkowski F., et al. Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges 2008, 6:1066-1069.
83. Baltaci M., Fritsch P., Weber F., et al. Treatment with gefitinib (ZD 1839) in a patient with advanced cutaneous squamous cell carcinoma. Br J Dermatol 2005, 153:234-236.
84. Cohen E.E., Rosen F., Stadler W.M., et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003, 21:1980-1987.
85. Stewart J.S., Cohen E.E., Licitra L., et al. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2009, 27:1864-1871. [corrected].
86. Toma S., Bonelli L., Sartoris A., et al. 13-cis retinoic acid in head and neck cancer chemoprevention: Results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep 2004, 11:1297-1305.
87. Brewster A.M., Lee J.J., Clayman G.L., et al. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 2007, 25:1974-1978.
88. Abou-Ayache R., Thierry A., Bridoux F., et al. Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy. Transplant Proc 2007, 39:2592-2594.
89. Schena F.P., Pascoe M.D., Alberu J., et al. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-Month efficacy and safety results from the CONVERT trial. Transplantation 2009, 87:233-242.
90. Rival-Tringali A.L., Euvrard S., Decullier E., et al. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas. Anticancer Res 2009, 29:1927-1932.
91. Berg D., Otley C.C. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002, 47:1-17. quiz: 18-20.
92. Jennings L., Schmults C.D. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol 2010, 3:39-48.
93. Willey A., Mehta S., Lee P.K. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg 2010, 36:652-658.
94. Wright T.I., Spencer J.M., Flowers F.P. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol 54 2006, 933-946.
95. Harwood C.A., Leedham-Green M., Leigh I.M., et al. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: A 16-year retrospective study. Arch Dermatol 2005, 141:456-464.
96. Bavinck J.N., Tieben L.M., Van der Woude F.J., et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study. J Clin Oncol 1995, 13:1933-1938.
97. McKenna D.B., Murphy G.M. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999, 140:656-660.
98. Marquez C., Bair S.M., Smithberger E., et al. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients. J Drugs Dermatol 2010, 9:753-758.
99. Chambon P.T. The retinoid signaling pathway: Molecular and genetic analysis. Semin Cell Biol 1999, 5:115-125.